MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
CHEBI:134548 chebi:134548 QHPYSHVSWAOLHS-PVNBSDFKSA-N | N-pentacosanoylsphingosine C25 ceramide Cer(d18:1/25:0) N-(pentacosanoyl)-ceramide N-(pentacosanoyl)-sphing-4-enine N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]pentacosanamide N-pentacosanoylsphing-4-enine ceramide (d18:1/25:0) |
| hmdb:HMDB0004957 QHPYSHVSWAOLHS-PVNBSDFKSA-N | Cer(d18:1/25:0) (2S,3R,4E)-2-Acylaminooctadec-4-ene-1,3-diol (2S,3R,4E)-2-acylamino-1,3-Octadec-4-enediol C25 Ceramide Cer Cer d18:1/25:0 Ceramide Ceramide (d18:1,C25:0) Ceramide (d18:1/25:0) Ceramide(d18:1/25:0) N-(Pentacosanoyl)-ceramide N-(Pentacosanoyl)-sphing-4-enine N-(pentacosanoyl)-ceramide N-Acylsphingosine N-Pentacosanoylsphing-4-enine N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-octadecanamide N-[(2S,3R,4E)-1,3-dihydroxyoctadec-4-en-2-yl]pentacosanamide |
lipidmaps:LMSP02010013 lipidmapsM:LMSP02010013 QHPYSHVSWAOLHS-PVNBSDFKSA-N | Cer(d18:1/25:0) Cer 43:1 Cer[NS] N-(pentacosanoyl)-ceramide N-(pentacosanoyl)-sphing-4-enine O2 |
vmhM:crm_ptcsa vmhM:crm_ptcsa vmhmetabolite:crm_ptcsa vmhmetabolite:crm_ptcsa QHPYSHVSWAOLHS-PVNBSDFKSA-N | Ceramide (d18:1/25:0) (2S,3R,4E)-2-Acylaminooctadec-4-ene-1,3-diol (2S,3R,4E)-2-acylamino-1,3-Octadec-4-enediol C25 Ceramide Cell signaling agent Cellular membrane Cer Cer d18:1/25:0 Cer(d18:1/25:0) Ceramide Ceramide (d18:1,C25:0) Ceramide (d18:1/25:0) Ceramide(d18:1/25:0) Chaos Cytoplasma Dietary supplement Digestion Extracellular region Faecal Faeces Fauna Fecal Inflammation agent Inner membrane Insulin resistance Insulin resistance syndrome Kidneys Lipid metabolic process Membrane integrity agent Membrane stability agent Metabolic syndrome x Myelin N-(Pentacosanoyl)-ceramide N-(Pentacosanoyl)-sphing-4-enine N-Acylsphingosine N-Pentacosanoylsphing-4-enine N-[(1S,2R,3E)-2-Hydroxy-1-(hydroxymethyl)-3-heptadecenyl]-octadecanamide Necrotic cell death Necrotic process Neuron Nutraceutical Reaven's syndrome Secondary messenger Signal transduction Signaling agent Signalling molecule Stool Striated muscle Surface-active agent Syndrome x Testes Testis Thrombocyte Type i pcd Type ii pcd |
hmdb:HMDB04957 vmhM:cer1825 vmhM:cer1825 vmhM:crm_ptcosac vmhM:crm_ptcosac vmhM:M_crm_ptcsa | secondary/obsolete/fantasy identifier |